Topic,Text,vader,sentiment
5.1 topic 0,fter increase year net u pet population increase historic pre pandemic level pet continue fuel long term growth healthcare need lifetime illustrate graph bar total clinical visit age group green line diagnostic utilization clinical visit clinical visit include diagnostic pet age diagnostic utilization increase huge step pet population pandemic result flurry clinical visit puppy kitten low diagnostic intensity large cohort pet moving leave right graph continue old ongoing phenomenon snapshot time illustrative purpose expect increase senior pet visit increase geriatric pet compare increase diagnostic utilization pet age amplify bolus pandemic pet old point significant tailwind business,0.9349,"{'neg': 0.031, 'neu': 0.779, 'pos': 0.19, 'compound': 0.9349}"
5.2 topic 1,let update capital deployment continue successfully execute discipline capital deployment strategy combination strategic return capital shareholder shortly quarter end complete acquisition olink great welcome new colleague company early month know olink lead provider generation proteomic solution addition olink prove transformative technology highly complementary industry lead mass spectrometer olink advance leadership great addition differentiate protein research ecosystem world class commercial engine enable u bring technology scientist world,0.9493,"{'neg': 0.0, 'neu': 0.782, 'pos': 0.218, 'compound': 0.9493}"
5.3 topic 2,gross profit margin second quarter adjust operate profit margin basis point favorable impact cost saving initiative offset low volume adjust diluted net earning common share essentially flat year year generate billion free cash flow quarter billion year date result year date free cash flow net income conversion ratio additionally second quarter july repurchase approximately million share remain bias capital deployment believe repurchase provide attractive return strength long term organic growth earning cash flow outlook let close look result portfolio color end market today,0.9682,"{'neg': 0.063, 'neu': 0.665, 'pos': 0.272, 'compound': 0.9682}"
5.4 topic 3,yeah hi thank color hope tell u expect medicaid mlr half year kind bridge assumption use guess think magnitude mlr improvement plus composite rate helpful know u sense state update rate inside composite rate leave term normalize profitability work second half rate state think bring basically close line target level profitability thank,0.9652,"{'neg': 0.019, 'neu': 0.618, 'pos': 0.363, 'compound': 0.9652}"
5.5 topic 4,believe healthcare deliver low cost low acuity high comfort location possible optimal case right person home resme clear leader sleep apnea market billion people globally end market remain significantly penetrate lead industry digital health solution approximately billion night medical datum cloud million cloud connectable medical device sell country worldwide leverage identify datum therapy solution low cost improve outcome bend curve chronic disease progression,0.8316,"{'neg': 0.084, 'neu': 0.716, 'pos': 0.2, 'compound': 0.8316}"
5.6 topic 5,think dynamic play refer patient identification phase going little bit difference week week month month add patient single week add single month acquire new datum regular basis recently share chris day new ai engine deploy identify significant number additional code fa patient begin launch start patient engage physician able reach efficiency certainty board think promise new patient come,0.9393,"{'neg': 0.0, 'neu': 0.7, 'pos': 0.3, 'compound': 0.9393}"
5.7 topic 6,sure firstly mean china come ahead expectation right mean driver beat mean bit fact mean q china decline q decline mean large end market pharma decline decline q steady improvement china second half year low base year guide low double digit decline china sort watch datum good thing happen china compare lc growth rate sort interesting fact time long time china lc decline rest world right china decline high single digit overall decline lc bit higher,0.8519,"{'neg': 0.05, 'neu': 0.789, 'pos': 0.161, 'compound': 0.8519}"
5.8 topic 7,innovation leader idexx growth continue outpace sector help customer grow fast progress reflect solid second quarter cag diagnostic recur revenue growth support key execution driver include continue solid new business gain sustain high plus customer retention rate solid net price realization align value deliver idexx focus innovation companion animal diagnostic result highly compelling portfolio product service highly capable commercial team support customer combination helped drive record second quarter global premium instrument placement double digit growth instal base premium instrument consecutive quarter double digit cag diagnostic recur revenue growth europe,0.9884,"{'neg': 0.0, 'neu': 0.631, 'pos': 0.369, 'compound': 0.9884}"
